Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
Germany
/
Pharmaceuticals & Biotech
/
SCHOTT Pharma KGaA
1SXP
SCHOTT Pharma KGaA
Aging Population And Biologics Growth Will Fuel Advanced Packaging
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 12 Analysts
Published
30 Jun 25
Updated
20 Aug 25
0
Set Fair Value
0
votes
Share
AnalystHighTarget
's Fair Value
€36.00
33.9% undervalued
intrinsic discount
20 Aug
€23.80
Loading
1Y
-22.2%
7D
4.4%
Author's Valuation
€36.0
33.9% undervalued
intrinsic discount
AnalystHighTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystHighTarget Fair Value
€36.0
33.9% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
0
1b
2020
2021
2022
2023
2024
2025
2026
2027
2028
Revenue €1.4b
Earnings €249.8m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
9.06%
Life Sciences revenue growth rate
0.33%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
5.21%
Calculation
€249.77m
Earnings '28
x
25.85x
PE Ratio '28
=
€6.46b
Market Cap '28
€6.46b
Market Cap '28
/
155.74m
No. shares '28
=
€41.46
Share Price '28
€41.46
Share Price '28
Discounted to 2025 @ 5.22% p.a.
=
€35.60
Fair Value '25